NobleOak Life Ltd (AU:NOL)
ASX:NOL
Want to see AU:NOL full AI Analyst Report?
Top Page
NobleOak Life Ltd
(Sydney:NOL)
Select Model
Select Model
Rating:62Neutral
Price Target:
AU$1.50
▲(15.38% Upside)
Action:ReiteratedDate:01/04/26
The score is driven primarily by solid financial fundamentals—strong recent cash generation and very low leverage—tempered by highly volatile revenue and uneven profitability. Technical signals are slightly negative with the stock trading below key moving averages, while valuation appears moderate based on the P/E.
Positive Factors
Conservative balance sheet / very low leverage
Very low leverage and A$88.9M equity provide durable financial flexibility for an insurer: capacity to absorb claim shocks, meet regulatory capital needs, and underwrite growth without frequent external funding. This strengthens long-term solvency and strategic optionality.
Negative Factors
Pronounced revenue volatility
Large year-to-year revenue swings materially weaken predictability of premiums and earnings. For an insurer, volatile top-line inflows complicate pricing, reserve setting and capital planning, increasing the risk that underwriting and investment plans will be misaligned with cash needs.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet / very low leverage
Very low leverage and A$88.9M equity provide durable financial flexibility for an insurer: capacity to absorb claim shocks, meet regulatory capital needs, and underwrite growth without frequent external funding. This strengthens long-term solvency and strategic optionality.
Read all positive factors
NobleOak Life Ltd (NOL) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$118.97M
Dividend YieldN/A
Average Volume (3M)19.05K
Price to Earnings (P/E)5.2
Beta (1Y)0.08
Revenue Growth19.44%
EPS Growth-63.67%
CountryAU
Employees155
SectorFinancial
Sector Strength70
IndustryInsurance - Life
Share Statistics
EPS (TTM)0.10
Shares Outstanding92,943,520
10 Day Avg. Volume14,036
30 Day Avg. Volume19,047
Financial Highlights & Ratios
PEG Ratio-0.71
Price to Book (P/B)1.57
Price to Sales (P/S)1.13
P/FCF Ratio2.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.85Price Target Upside119.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.21
Revenue Forecast (FY)AU$522.98M
NobleOak Life Ltd Business Overview & Revenue Model
Company Description
NobleOak Life Limited manufactures and distributes life insurance products in Australia. The company offers term death, total and permanent disability, trauma, and income protection and business expenses insurance products. It sells its products t...
How the Company Makes Money
NobleOak Life Ltd makes money primarily from premium income collected from policyholders on the life insurance policies it underwrites. Those premiums are used to cover claims, operating costs, commissions/fees paid for distribution, and to genera...
NobleOak Life Ltd Financial Statement Overview
Summary
Income Statement
57
Neutral
Balance Sheet
74
Positive
Cash Flow
71
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 315.95M | 123.99M | 386.65M | 343.40M | 75.43M | 61.32M |
| Gross Profit | 315.95M | 123.99M | 50.26M | 181.86M | 169.78M | 61.32M |
| EBITDA | 12.72M | 15.42M | 20.33M | 18.67M | 4.22M | 8.52M |
| Net Income | 5.18M | 7.12M | 9.28M | 7.99M | 1.69M | 4.90M |
Balance Sheet | ||||||
| Total Assets | 600.63M | 567.29M | 463.73M | 251.15M | 121.08M | 72.62M |
| Cash, Cash Equivalents and Short-Term Investments | 66.22M | 0.00 | 63.96M | 30.26M | 30.26M | 31.41M |
| Total Debt | 8.43M | 4.58M | 5.26M | 5.83M | 556.00K | 1.46M |
| Total Liabilities | 505.13M | 478.36M | 392.33M | 131.31M | 9.45M | -12.00M |
| Stockholders Equity | 95.50M | 88.94M | 71.41M | 119.84M | 111.63M | 84.62M |
Cash Flow | ||||||
| Free Cash Flow | 49.80M | 58.63M | 44.02M | 129.66M | 23.49M | -2.17M |
| Operating Cash Flow | 49.97M | 58.74M | 44.42M | 130.14M | 27.98M | -720.00K |
| Investing Cash Flow | -60.57M | -45.59M | -29.86M | -108.81M | -53.33M | -10.37M |
| Financing Cash Flow | 419.00K | 8.44M | -1.01M | -1.18M | 23.77M | 14.42M |
NobleOak Life Ltd Technical Analysis
Neutral
1.30
Price Trends
1.32
Negative
1.37
Negative
1.41
Negative
Market Momentum
-0.03
Negative
49.60
Neutral
60.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NOL, the sentiment is Neutral. The current price of 1.3 is above the 20-day moving average (MA) of 1.23, below the 50-day MA of 1.32, and below the 200-day MA of 1.41, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 49.60 is Neutral, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:NOL.
NobleOak Life Ltd Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | AU$3.05B | 20.16 | 15.91% | ― | 28.84% | ― | |
62 Neutral | AU$118.97M | 5.15 | 5.62% | ― | 19.44% | -63.67% | |
61 Neutral | AU$296.45M | 10.89 | 12.36% | 2.86% | -38.87% | 60.62% | |
57 Neutral | AU$781.64M | 9.15 | 12.70% | 11.71% | -8.26% | 5.26% | |
56 Neutral | AU$377.55M | 10.16 | 0.24% | ― | 12.63% | -90.91% | |
53 Neutral | AU$792.45M | 7.11 | 6.34% | 4.63% | 44.60% | -7.74% |
* Financial Sector Average
AU:NOL
NobleOak Life Ltd
1.28
-0.09
-6.91%
AU:CVW
Clearview Wealth Limited
0.64
0.19
41.11%
AU:ZIP
Zip Co Ltd.
2.43
0.71
40.87%
AU:PPM
Pepper Money Ltd
1.73
0.44
34.66%
AU:COG
COG Financial Services Limited
1.36
0.01
0.89%
AU:MYS
Mystate Limited
4.61
0.86
22.77%
NobleOak Life Ltd Corporate Events
NobleOak Director Anthony Brown Increases Shareholding via On‑Market Purchase
Apr 22, 2026
NobleOak Life Limited has disclosed a change in the interests of director Anthony Ross Brown, who increased his holding in the company through an on‑market purchase of 4,394 fully paid ordinary shares for a total consideration of $5,360.68. ...
NobleOak Director Anthony Brown Increases Shareholding via On-Market Purchase
Apr 17, 2026
NobleOak Life Limited has reported a change in the interests of director Anthony Ross Brown in the company’s ordinary shares. Brown holds both direct and indirect interests, with indirect holdings controlled through Brohok Investments Co Pty...
NobleOak hits $500m in-force milestone as partnerships and AI drive HY26 growth
Feb 26, 2026
NobleOak Life reported half-year 2026 results showing in-force premiums up 19% to $505 million, marking the halfway point to its $1 billion target, with underlying NPAT rising 11% to $9.6 million and a solid capital adequacy multiple of 174%. Grow...
NobleOak Sets Date for HY26 Results and Investor Webcast
Feb 6, 2026
NobleOak Life Limited has announced it will release its financial results for the six months ended 31 December 2025 on 27 February 2026, followed by a live webcast briefing for analysts and investors hosted by CEO Anthony Brown and CFO Scott Pears...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.